TY - JOUR
T1 - Computer-aided diagnosis of prostate cancer using multiparametric MRI and clinical features
T2 - A patient-level classification framework
AU - Mehta, Pritesh
AU - Antonelli, Michela
AU - Ahmed, Hashim U.
AU - Emberton, Mark
AU - Punwani, Shonit
AU - Ourselin, Sébastien
N1 - Funding Information:
PM’s research is supported by the UCL EPSRC Centre for Doctoral Training in Intelligent, Integrated Imaging In Healthcare (i4health) (EP/L016478/1). MA’s research is supported by the Wellcome/EPSRC Centre for Medical Engineering King’s College London and by the London Medical Imaging and AI Centre for Value-Based Healthcare. HUA’s research is supported by core funding from the UK’s National Institute of Health Research (NIHR) Imperial Biomedical Research Centre. HUA currently also receives funding from the Wellcome Trust, Medical Research Council (UK), Cancer Research UK, Prostate Cancer UK, The Urology Foundation, BMA Foundation, Imperial Health Charity, Sonacare Inc., Trod Medical, and Sophiris Biocorp for trials in prostate cancer. ME and SP receive research support from the University College London/University College London Hospital (UCL/UCLH) Biomedical Research Centre
Publisher Copyright:
© 2021
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/10
Y1 - 2021/10
N2 - Computer-aided diagnosis (CAD) of prostate cancer (PCa) using multiparametric magnetic resonance imaging (mpMRI) is actively being investigated as a means to provide clinical decision support to radiologists. Typically, these systems are trained using lesion annotations. However, lesion annotations are expensive to obtain and inadequate for characterizing certain tumor types e.g. diffuse tumors and MRI invisible tumors. In this work, we introduce a novel patient-level classification framework, denoted PCF, that is trained using patient-level labels only. In PCF, features are extracted from three-dimensional mpMRI and derived parameter maps using convolutional neural networks and subsequently, combined with clinical features by a multi-classifier support vector machine scheme. The output of PCF is a probability value that indicates whether a patient is harboring clinically significant PCa (Gleason score ≥3+4) or not. PCF achieved mean area under the receiver operating characteristic curves of 0.79 and 0.86 on the PICTURE and PROSTATEx datasets respectively, using five-fold cross-validation. Clinical evaluation over a temporally separated PICTURE dataset cohort demonstrated comparable sensitivity and specificity to an experienced radiologist. We envision PCF finding most utility as a second reader during routine diagnosis or as a triage tool to identify low-risk patients who do not require a clinical read.
AB - Computer-aided diagnosis (CAD) of prostate cancer (PCa) using multiparametric magnetic resonance imaging (mpMRI) is actively being investigated as a means to provide clinical decision support to radiologists. Typically, these systems are trained using lesion annotations. However, lesion annotations are expensive to obtain and inadequate for characterizing certain tumor types e.g. diffuse tumors and MRI invisible tumors. In this work, we introduce a novel patient-level classification framework, denoted PCF, that is trained using patient-level labels only. In PCF, features are extracted from three-dimensional mpMRI and derived parameter maps using convolutional neural networks and subsequently, combined with clinical features by a multi-classifier support vector machine scheme. The output of PCF is a probability value that indicates whether a patient is harboring clinically significant PCa (Gleason score ≥3+4) or not. PCF achieved mean area under the receiver operating characteristic curves of 0.79 and 0.86 on the PICTURE and PROSTATEx datasets respectively, using five-fold cross-validation. Clinical evaluation over a temporally separated PICTURE dataset cohort demonstrated comparable sensitivity and specificity to an experienced radiologist. We envision PCF finding most utility as a second reader during routine diagnosis or as a triage tool to identify low-risk patients who do not require a clinical read.
KW - Computer-aided diagnosis
KW - Convolutional neural network
KW - Multiparametric magnetic resonance Imaging
KW - Prostate cancer
KW - Prostate-specific antigen density
KW - Support vector machine
UR - http://www.scopus.com/inward/record.url?scp=85109444067&partnerID=8YFLogxK
U2 - 10.1016/j.media.2021.102153
DO - 10.1016/j.media.2021.102153
M3 - Article
AN - SCOPUS:85109444067
SN - 1361-8415
VL - 73
JO - Medical Image Analysis
JF - Medical Image Analysis
M1 - 102153
ER -